MV
MVSTW
Microvast Holdings, Inc.
$0.0449
0.00%
$3.2M
No data for this timeframe.
Vol
Market Cap$3.2M
Cap SizeNano Cap
Inst. Holders2 funds
Inst. Value$87.00
Inst. Activity0 buys / 1 sells
SEC Reports2
Exchange Nasdaq·Sector Miscellaneous Electrical Machinery, Equipment & Supplies·Inc. DE·CIK 0001760689·Prev Close $0.0449
Recent Activity
May 28, 2026
SEC
Microvast's Chief Accounting Officer resigned effective May 27, 2026, and CEO Yang Wu converted a $25.0M outstanding loa
8-K — Impact 6/10
May 11, 2026
SEC
Microvast reported Q1 2026 revenue of $60.6M, a 48.0% decline YoY from $116.5M, driven by regulatory shifts in Korea/Ind
8-K — Impact 7/10
Inst.
UBS Group AG — TRIM
1,757 shares ($327.00)
Latest Reports
BEARISH
8-K
6/10
Microvast's Chief Accounting Officer resigned effective May 27, 2026, and CEO Yang Wu converted a $25.0M outstanding loa
May 28, 2026
BEARISH
8-K
7/10
Microvast reported Q1 2026 revenue of $60.6M, a 48.0% decline YoY from $116.5M, driven by regulatory shifts in Korea/Ind
May 11, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| BANK OF AMERICA CORP | — | — |
| UBS Group AG | $87.00 | TRIM |
2 institutional holders with $87.00 total value (489 shares) as of 2025-Q3. Top holders: BANK, UBS.
Top Institutional Holders — 2025-Q3
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | BANK OF AMERICA CORP /DE/ | 2 | $0.00 | 0.0% | — |
| 2 | UBS Group AG | 487 | $87.00 | 100.0% | TRIM -68.6% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| UBS Group AG | TRIM | 5,604 | 1,757 | -68.6% | $327.00 | 2025-Q1 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
2 SEC filing reports analyzed. Sentiment: 0 bullish, 2 bearish, 0 mixed, 0 neutral. Avg impact: 6.5/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.1B | 3.4% | — |
| Next Q 2026-09-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.1B | 3.4% | — |
| Current FY 2026-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.4B | 4.0% | — |
| Next FY 2027-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.6B | 33.1% | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.